ID   MTU1_HUMAN              Reviewed;         421 AA.
AC   O75648; A8K3U7; Q05C99; Q5W9C8; Q66K31; Q6ICC3; Q9NWC1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 2.
DT   10-MAY-2017, entry version 131.
DE   RecName: Full=Mitochondrial tRNA-specific 2-thiouridylase 1;
DE            EC=2.8.1.14 {ECO:0000250|UniProtKB:Q12093};
DE   AltName: Full=MTO2 homolog;
GN   Name=TRMU; Synonyms=MTU1, TRMT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16513084; DOI=10.1016/j.bbrc.2006.02.078;
RA   Yan Q., Bykhovskaya Y., Li R., Mengesha E., Shohat M., Estivill X.,
RA   Fischel-Ghodsian N., Guan M.-X.;
RT   "Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-
RT   methyltransferase is a putative nuclear modifier gene for the
RT   phenotypic expression of the deafness-associated 12S rRNA mutations.";
RL   Biochem. Biophys. Res. Commun. 342:1130-1136(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF ASP-16.
RX   PubMed=15509579; DOI=10.1074/jbc.M409306200;
RA   Umeda N., Suzuki T., Yukawa M., Ohya Y., Shindo H., Watanabe K.,
RA   Suzuki T.;
RT   "Mitochondria-specific RNA-modifying enzymes responsible for the
RT   biosynthesis of the wobble base in mitochondrial tRNAs. Implications
RT   for the molecular pathogenesis of human mitochondrial diseases.";
RL   J. Biol. Chem. 280:1613-1624(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Embryo, and Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15944150; DOI=10.1074/jbc.M504247200;
RA   Yan Q., Li X., Faye G., Guan M.-X.;
RT   "Mutations in MTO2 related to tRNA modification impair mitochondrial
RT   gene expression and protein synthesis in the presence of a paromomycin
RT   resistance mutation in mitochondrial 15 S rRNA.";
RL   J. Biol. Chem. 280:29151-29157(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   VARIANT SER-10, CHARACTERIZATION OF VARIANT SER-10, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16826519; DOI=10.1086/506389;
RA   Guan M.-X., Yan Q., Li X., Bykhovskaya Y., Gallo-Teran J., Hajek P.,
RA   Umeda N., Zhao H., Garrido G., Mengesha E., Suzuki T.,
RA   del Castillo I., Peters J.L., Li R., Qian Y., Wang X., Ballana E.,
RA   Shohat M., Lu J., Estivill X., Watanabe K., Fischel-Ghodsian N.;
RT   "Mutation in TRMU related to transfer RNA modification modulates the
RT   phenotypic expression of the deafness-associated mitochondrial 12S
RT   ribosomal RNA mutations.";
RL   Am. J. Hum. Genet. 79:291-302(2006).
RN   [11]
RP   VARIANTS LFIT HIS-77 AND ASP-272, AND VARIANTS SER-10; SER-14 AND
RP   MET-279.
RX   PubMed=19732863; DOI=10.1016/j.ajhg.2009.08.004;
RA   Zeharia A., Shaag A., Pappo O., Mager-Heckel A.-M., Saada A.,
RA   Beinat M., Karicheva O., Mandel H., Ofek N., Segel R., Marom D.,
RA   Roetig A., Tarassov I., Elpeleg O.;
RT   "Acute infantile liver failure due to mutations in the TRMU gene.";
RL   Am. J. Hum. Genet. 85:401-407(2009).
RN   [12]
RP   ERRATUM.
RA   Zeharia A., Shaag A., Pappo O., Mager-Heckel A.-M., Saada A.,
RA   Beinat M., Karicheva O., Mandel H., Ofek N., Segel R., Marom D.,
RA   Roetig A., Tarassov I., Elpeleg O.;
RL   Am. J. Hum. Genet. 86:295-295(2010).
CC   -!- FUNCTION: Catalyzes the 2-thiolation of uridine at the wobble
CC       position (U34) of mitochondrial tRNA(Lys), tRNA(Glu) and
CC       tRNA(Gln). Required for the formation of 5-taurinomethyl-2-
CC       thiouridine (tm5s2U) of mitochondrial tRNA(Lys), tRNA(Glu), and
CC       tRNA(Gln) at the wobble position. ATP is required to activate the
CC       C2 atom of the wobble base. {ECO:0000269|PubMed:15509579,
CC       ECO:0000269|PubMed:15944150, ECO:0000269|PubMed:16826519}.
CC   -!- CATALYTIC ACTIVITY: A [protein]-S-sulfanyl-L-cysteine + 5-
CC       taurinomethyluridine(34) in tRNA + ATP + reduced acceptor = a
CC       [protein]-L-cysteine + 5-taurinomethyl-2-thiouridine(34) in tRNA +
CC       AMP + diphosphate + acceptor. {ECO:0000250|UniProtKB:Q12093}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:15509579,
CC       ECO:0000269|PubMed:15944150, ECO:0000269|PubMed:16513084,
CC       ECO:0000269|PubMed:16826519}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O75648-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75648-2; Sequence=VSP_035395;
CC       Name=3;
CC         IsoId=O75648-3; Sequence=VSP_035391, VSP_035392, VSP_035395;
CC         Note=Ref.7 (AAH80631) sequence is in conflict in position:
CC         14:K->N. {ECO:0000305};
CC       Name=4;
CC         IsoId=O75648-4; Sequence=VSP_035391, VSP_035392;
CC       Name=5;
CC         IsoId=O75648-5; Sequence=VSP_035393, VSP_035394;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Abundantly expressed in tissues
CC       with high metabolic rates including heart, liver, kidney, and
CC       brain. {ECO:0000269|PubMed:16513084}.
CC   -!- POLYMORPHISM: The polymorphism Ser-10 aggravates the mitochondrial
CC       dysfunction associated with a mitochondrial 12S ribosomal RNA
CC       (rRNA) A1555G mutation that has been associated with
CC       aminoglycoside-induced and non-syndromic deafness [MIM:580000].
CC   -!- DISEASE: Liver failure, infantile, transient (LFIT) [MIM:613070]:
CC       A transient disorder of hepatic function characterized by elevated
CC       liver enzymes, jaundice, vomiting, coagulopathy,
CC       hyperbilirubinemia, increased serum lactate. Patients who survive
CC       the initial acute episode can recover, show normal development and
CC       have no recurrence. {ECO:0000269|PubMed:19732863}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: During the reaction, ATP is used to activate the C2
CC       atom of U34 by adenylation. After this, the persulfide sulfur on
CC       the catalytic cysteine is transferred to the C2 atom of the wobble
CC       base (U34) of mitochondrial tRNA(Lys), tRNA(Glu) and tRNA(Gln).
CC       The reaction probably involves hydrogen sulfide that is generated
CC       from the persulfide intermediate and that acts as nucleophile
CC       towards the activated C2 atom on U34. Subsequently, a transient
CC       disulfide bond is formed between the two active site cysteine
CC       residues (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the MnmA/TRMU family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a 5-methylaminomethyl-2-
CC       methyltransferase involved in tRNA modification.
CC       {ECO:0000305|PubMed:16513084}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY062123; AAL38183.1; -; mRNA.
DR   EMBL; AF448221; AAL35970.1; -; Genomic_DNA.
DR   EMBL; AB178028; BAD66875.1; -; mRNA.
DR   EMBL; CR456445; CAG30331.1; -; mRNA.
DR   EMBL; AK001002; BAA91462.1; -; mRNA.
DR   EMBL; AK290712; BAF83401.1; -; mRNA.
DR   EMBL; AL031588; CAB38414.1; -; Genomic_DNA.
DR   EMBL; AL031588; CAP58845.1; -; Genomic_DNA.
DR   EMBL; CH471138; EAW73422.1; -; Genomic_DNA.
DR   EMBL; CH471138; EAW73426.1; -; Genomic_DNA.
DR   EMBL; BC027991; AAH27991.1; -; mRNA.
DR   EMBL; BC080631; AAH80631.1; -; mRNA.
DR   CCDS; CCDS14075.1; -. [O75648-1]
DR   CCDS; CCDS63510.1; -. [O75648-2]
DR   RefSeq; NP_001269712.1; NM_001282783.1.
DR   RefSeq; NP_001269713.1; NM_001282784.1.
DR   RefSeq; NP_001269714.1; NM_001282785.1. [O75648-2]
DR   RefSeq; NP_060476.2; NM_018006.4. [O75648-1]
DR   UniGene; Hs.439524; -.
DR   ProteinModelPortal; O75648; -.
DR   BioGrid; 120814; 6.
DR   IntAct; O75648; 2.
DR   STRING; 9606.ENSP00000290846; -.
DR   iPTMnet; O75648; -.
DR   PhosphoSitePlus; O75648; -.
DR   BioMuta; TRMU; -.
DR   EPD; O75648; -.
DR   MaxQB; O75648; -.
DR   PaxDb; O75648; -.
DR   PeptideAtlas; O75648; -.
DR   PRIDE; O75648; -.
DR   DNASU; 55687; -.
DR   Ensembl; ENST00000290846; ENSP00000290846; ENSG00000100416. [O75648-1]
DR   Ensembl; ENST00000381019; ENSP00000370407; ENSG00000100416. [O75648-2]
DR   Ensembl; ENST00000457572; ENSP00000407700; ENSG00000100416. [O75648-5]
DR   GeneID; 55687; -.
DR   KEGG; hsa:55687; -.
DR   UCSC; uc003bhp.4; human. [O75648-1]
DR   CTD; 55687; -.
DR   DisGeNET; 55687; -.
DR   GeneCards; TRMU; -.
DR   HGNC; HGNC:25481; TRMU.
DR   HPA; HPA035273; -.
DR   HPA; HPA043300; -.
DR   MalaCards; TRMU; -.
DR   MIM; 580000; phenotype.
DR   MIM; 610230; gene.
DR   MIM; 613070; phenotype.
DR   neXtProt; NX_O75648; -.
DR   OpenTargets; ENSG00000100416; -.
DR   Orphanet; 217371; Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins.
DR   Orphanet; 254864; Mitochondrial myopathy with reversible cytochrome C oxidase deficiency.
DR   Orphanet; 90641; Mitochondrial non-syndromic sensorineural deafness.
DR   Orphanet; 168609; Mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure.
DR   PharmGKB; PA142670701; -.
DR   eggNOG; KOG2805; Eukaryota.
DR   eggNOG; COG0482; LUCA.
DR   GeneTree; ENSGT00390000014323; -.
DR   HOVERGEN; HBG108157; -.
DR   InParanoid; O75648; -.
DR   KO; K21027; -.
DR   OMA; LHKINFA; -.
DR   OrthoDB; EOG091G0BKX; -.
DR   PhylomeDB; O75648; -.
DR   TreeFam; TF105611; -.
DR   BRENDA; 2.1.1.61; 2681.
DR   Reactome; R-HSA-6787450; tRNA modification in the mitochondrion.
DR   ChiTaRS; TRMU; human.
DR   GeneWiki; TRMU; -.
DR   GenomeRNAi; 55687; -.
DR   PRO; PR:O75648; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100416; -.
DR   CleanEx; HS_TRMT1; -.
DR   CleanEx; HS_TRMU; -.
DR   ExpressionAtlas; O75648; baseline and differential.
DR   Genevisible; O75648; HS.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016783; F:sulfurtransferase activity; IEA:InterPro.
DR   GO; GO:0000049; F:tRNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0070903; P:mitochondrial tRNA thio-modification; IBA:GO_Central.
DR   GO; GO:0002143; P:tRNA wobble position uridine thiolation; IBA:GO_Central.
DR   CDD; cd01998; tRNA_Me_trans; 1.
DR   Gene3D; 2.30.30.280; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   HAMAP; MF_00144; tRNA_thiouridyl_MnmA; 1.
DR   InterPro; IPR023382; Adenine_a_hdrlase_dom.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR004506; tRNA-specific_2-thiouridylase.
DR   PANTHER; PTHR11933; PTHR11933; 1.
DR   TIGRFAMs; TIGR00420; trmU; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Disease mutation; Disulfide bond; Mitochondrion; Nucleotide-binding;
KW   Polymorphism; Reference proteome; RNA-binding; Transferase;
KW   tRNA processing; tRNA-binding.
FT   CHAIN         1    421       Mitochondrial tRNA-specific 2-
FT                                thiouridylase 1.
FT                                /FTId=PRO_0000121708.
FT   NP_BIND      10     17       ATP. {ECO:0000250}.
FT   REGION       96     98       Interaction with target base in tRNA.
FT                                {ECO:0000250}.
FT   REGION      171    173       Interaction with tRNA. {ECO:0000250}.
FT   REGION      334    335       Interaction with tRNA. {ECO:0000250}.
FT   ACT_SITE    101    101       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    222    222       Cysteine persulfide intermediate.
FT                                {ECO:0000250}.
FT   BINDING      36     36       ATP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     126    126       ATP; via amide nitrogen. {ECO:0000250}.
FT   SITE        127    127       Interaction with tRNA. {ECO:0000250}.
FT   SITE        267    267       Interaction with tRNA. {ECO:0000250}.
FT   SITE        367    367       Interaction with tRNA. {ECO:0000250}.
FT   DISULFID    101    222       {ECO:0000250}.
FT   VAR_SEQ       1    154       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035391.
FT   VAR_SEQ     155    179       FEVRNAVKLLQAADSFKDQTFFLSQ -> MKKSLSRSTLRS
FT                                PKGFSEIGLKLEM (in isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035392.
FT   VAR_SEQ     161    166       VKLLQA -> RFPRMP (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035393.
FT   VAR_SEQ     167    421       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035394.
FT   VAR_SEQ     341    421       PCVLTLNQDGTVWVTAVQAVRALATGQFAVFYKGDECLGSG
FT                                KILRLGPSAYTLQKGQRRAGMATESPSDSPEDGPGLSPLL
FT                                -> CCVLQGGRVPGQREDPAAGAVCLHAPEGPAQSWDGH
FT                                (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15461802,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035395.
FT   VARIANT      10     10       A -> S (decreased activity;
FT                                dbSNP:rs11090865).
FT                                {ECO:0000269|PubMed:16826519,
FT                                ECO:0000269|PubMed:19732863}.
FT                                /FTId=VAR_027268.
FT   VARIANT      14     14       G -> S (in dbSNP:rs751248771).
FT                                {ECO:0000269|PubMed:19732863}.
FT                                /FTId=VAR_063428.
FT   VARIANT      25     25       R -> S (in dbSNP:rs2272938).
FT                                /FTId=VAR_046380.
FT   VARIANT      77     77       Y -> H (in LFIT; dbSNP:rs118203990).
FT                                {ECO:0000269|PubMed:19732863}.
FT                                /FTId=VAR_063429.
FT   VARIANT     148    148       E -> K (in dbSNP:rs34012206).
FT                                /FTId=VAR_046381.
FT   VARIANT     272    272       G -> D (in LFIT; dbSNP:rs118203991).
FT                                {ECO:0000269|PubMed:19732863}.
FT                                /FTId=VAR_063430.
FT   VARIANT     279    279       V -> M (in dbSNP:rs387907022).
FT                                {ECO:0000269|PubMed:19732863}.
FT                                /FTId=VAR_063431.
FT   VARIANT     398    398       R -> C (in dbSNP:rs34152016).
FT                                /FTId=VAR_046382.
FT   MUTAGEN      16     16       D->A: Loss of activity.
FT                                {ECO:0000269|PubMed:15509579}.
FT   CONFLICT    139    139       F -> L (in Ref. 4; BAA91462).
FT                                {ECO:0000305}.
SQ   SEQUENCE   421 AA;  47745 MW;  F06A57DED79BBE84 CRC64;
     MQALRHVVCA LSGGVDSAVA ALLLRRRGYQ VTGVFMKNWD SLDEHGVCTA DKDCEDAYRV
     CQILDIPFHQ VSYVKEYWND VFSDFLNEYE KGRTPNPDIV CNKHIKFSCF FHYAVDNLGA
     DAIATGHYAR TSLEDEEVFE QKHVKKPEGL FRNRFEVRNA VKLLQAADSF KDQTFFLSQV
     SQDALRRTIF PLGGLTKEFV KKIAAENRLH HVLQKKESMG MCFIGKRNFE HFLLQYLQPR
     PGHFISIEDN KVLGTHKGWF LYTLGQRANI GGLREPWYVV EKDSVKGDVF VAPRTDHPAL
     YRDLLRTSRV HWIAEEPPAA LVRDKMMECH FRFRHQMALV PCVLTLNQDG TVWVTAVQAV
     RALATGQFAV FYKGDECLGS GKILRLGPSA YTLQKGQRRA GMATESPSDS PEDGPGLSPL
     L
//
